Overview
AI-driven structure-based drug discovery using deep learning for binding prediction.
Details
Atomwise’s AtomNet predicts small-molecule binding to protein targets and powers internal programs plus 750+ academic and industry partnerships.
Tags
drug-discovery, structure-based, deep-learning, small-molecule, partnerships